Medfinder
Back to blog

Updated: March 26, 2026

What Is Zoryve? Uses, Dosage, and What You Need to Know in 2026

Author

Peter Daggett

Peter Daggett

Summarize with AI


Overview

A complete patient guide to Zoryve (roflumilast): what it is, what conditions it treats, how to use it, and everything you need to know in 2026.

Is Zoryve in stock near you?

Medfinder checks real pharmacy inventory — start a search and we'll find Zoryve near you.

Zoryve (roflumilast) is a prescription topical medication used to treat several common skin conditions: plaque psoriasis, atopic dermatitis (eczema), and seborrheic dermatitis. It's available as both a cream and a foam, comes in multiple strengths, and is applied once daily.

What makes Zoryve stand out is what it's not: it is not a topical corticosteroid. That matters because Zoryve can be used long-term, anywhere on the body — including sensitive areas like the face and skin folds — without the side effects that come with steroid-based treatments.

Who Makes Zoryve?

Zoryve is manufactured by Arcutis Biotherapeutics, Inc., a dermatology-focused biopharmaceutical company based in Westlake Village, California. The active ingredient, roflumilast, was previously only available in an oral tablet form (Daliresp) used to treat severe COPD. Arcutis developed the topical formulation for skin conditions, receiving its first FDA approval in July 2022.

Don't wait on hold.
Check live stock now.

What Conditions Does Zoryve Treat?

Zoryve is FDA-approved for three skin conditions, with different formulations for each:

Plaque Psoriasis: Zoryve cream 0.3% is FDA-approved for plaque psoriasis in adults and children 2 years and older. Zoryve foam 0.3% is approved for plaque psoriasis of the scalp and body in patients 12 and older. Psoriasis is a chronic immune-mediated condition causing itchy, raised, scaly plaques on the skin.

Atopic Dermatitis (Eczema): Zoryve cream 0.15% treats mild to moderate atopic dermatitis in adults and children 6 and older. Zoryve cream 0.05% treats the same condition specifically in children ages 2–5. Eczema causes dry, itchy, inflamed skin.

Seborrheic Dermatitis: Zoryve foam 0.3% is approved for seborrheic dermatitis in adults and children 9 and older. This condition causes scaly patches, red skin, and dandruff, often on the scalp, face, and chest.

What Are the Different Zoryve Formulations?

Zoryve comes in four distinct formulations — it's important to know which one your doctor has prescribed:

Zoryve cream 0.3%: For plaque psoriasis, age 2+. Available in 60-gram tubes.

Zoryve cream 0.15%: For atopic dermatitis, age 6+. Available in 60-gram tubes.

Zoryve cream 0.05%: For atopic dermatitis in children ages 2–5. Available in 60-gram tubes.

Zoryve foam 0.3%: For seborrheic dermatitis (age 9+) and plaque psoriasis of scalp/body (age 12+). Available in 60-gram aerosol canisters. Note: flammable — avoid fire and flame during and after application.

How Do You Use Zoryve?

Zoryve is applied once daily, every day, to the affected areas of skin. Follow these steps:

Apply a thin layer to the affected skin and rub in completely.

Wash your hands after applying (unless you're treating your hands).

Apply only to affected areas — not to healthy skin.

Do not use in or near your eyes, mouth, or vagina.

For foam: shake well before use. Apply to dry skin. Avoid fire and flame immediately after.

Unlike topical steroids, Zoryve has no restriction on duration of use or which body sites it can be applied to (except avoiding eyes, mouth, and genitals for internal use). It can be used on the face, neck, armpits, skin folds, and genitals — all areas where long-term steroid use is typically problematic.

38,004+ patients found their medications in stock
38K+
5-star rating

How Long Does Zoryve Take to Work?

Itch relief can begin within 24 hours of the first application for some patients. Visible clearing of psoriasis plaques and eczema typically takes 2–4 weeks of daily use, with significant improvement seen at the 8-week clinical trial endpoints. In clinical trials, about 40% of psoriasis patients achieved clear or almost clear skin at 8 weeks.

Who Should Not Use Zoryve?

Zoryve should not be used by:

Patients with moderate to severe liver impairment (Child-Pugh B or C)

Children younger than the age cutoffs for their specific formulation

Pregnant patients (safety not established; discuss with your doctor)

Patients with a known allergy to roflumilast or any ingredient in the formulation

Skip the calls, skip the stress.
50K+
Medications
Found
99%
Success
Rate
6+
Hours saved
on average

Want to Know More?

For a deeper look at how Zoryve works at a cellular level, see our article How Does Zoryve Work? Mechanism of Action Explained. If you need help finding a pharmacy that carries your Zoryve formulation, use medfinder.com — we call pharmacies for you and text you which ones can fill your prescription.

Frequently Asked Questions

Zoryve (roflumilast) is used to treat three skin conditions: plaque psoriasis (cream 0.3%, age 2+; foam 0.3%, age 12+), atopic dermatitis/eczema (cream 0.15%, age 6+; cream 0.05%, age 2-5), and seborrheic dermatitis (foam 0.3%, age 9+). It is applied once daily to affected areas.

No. Zoryve is not a corticosteroid. It's a phosphodiesterase-4 (PDE4) inhibitor — a completely different drug class. Unlike topical steroids, Zoryve does not cause skin thinning, does not have duration of use restrictions, and can be safely used long-term on any body site including the face and skin folds.

Many patients notice itch relief within 24 hours of the first application. Visible skin clearing typically begins within 2–4 weeks of daily use. In clinical trials, about 40% of patients with plaque psoriasis achieved clear or almost clear skin at 8 weeks of treatment.

Zoryve cream comes in 0.05%, 0.15%, and 0.3% strengths and is used for plaque psoriasis and atopic dermatitis. Zoryve foam only comes in 0.3% and is specifically formulated for use on the scalp and body for seborrheic dermatitis and plaque psoriasis. The foam is flammable — cream is not.

Yes. Zoryve cream 0.3% is approved for plaque psoriasis in children as young as 2 years. Zoryve cream 0.15% is approved for atopic dermatitis in children 6 and older. Zoryve cream 0.05% is approved specifically for atopic dermatitis in children ages 2–5. Zoryve foam is approved for seborrheic dermatitis in children 9 and older and for plaque psoriasis in children 12 and older.

How do I find Zoryve in stock near me?
Medfinder checks real pharmacy inventory and finds the pharmacies that have it.

Medfinder Editorial Standards

Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.

Read our editorial standards

Patients searching for Zoryve also looked for:

38,004 have already found their meds with Medfinder.

Start your search today.

38K+
5-star ratingTrusted by 38,004 Happy PatientsRead our reviews on Trustpilot →
      What med are you looking for?
⊙  Find Your Meds

Your information is private and never shared.

99% success rate
Fast turnaround time
Never call another pharmacy

Find Zoryve in stock